Capricor Therap (CAPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 310 | 1,005 | 1,671 | 2,666 | 3,999 |
| Gross Profit | 310 | 1,005 | 1,671 | 2,666 | 3,999 |
| Operating Expenses | 14,000 | 8,739 | 16,998 | 15,529 | 20,975 |
| Operating Income | -13,690 | -7,734 | -15,327 | -12,862 | -16,977 |
| Interest Expense | 0 | 0 | 0 | 399 | 345 |
| Other Income | 33 | 92 | 136 | 15,693 | -1,486 |
| Pre-tax Income | -13,657 | -7,642 | -15,191 | 2,431 | -18,807 |
| Net Income Continuous | -13,657 | -7,642 | -15,191 | 2,431 | -18,807 |
| Net Income | $-13,657 | $-7,642 | $-15,191 | $2,431 | $-18,807 |
| EPS Basic Total Ops | -0.88 | -2.06 | -5.17 | 1.00 | -10.10 |
| EPS Basic Continuous Ops | -0.88 | -2.06 | -5.17 | 1.05 | -10.14 |
| EPS Diluted Total Ops | -0.88 | -2.06 | -5.17 | 0.90 | -10.10 |
| EPS Diluted Continuous Ops | -0.88 | -2.06 | -5.17 | 0.91 | -10.14 |
| EPS Diluted Before Non-Recurring Items | -0.88 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-13,546 | $-7,562 | $-15,169 | $-12,718 | $-16,851 |